Citations (22)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
T. FURUTA, S. BABA, M. TAKASHIMA, H. FUTAMI, H. ARAI, M. KAJIMURA, H. HANAI, E. KANEKO. (1998) Effect of Helicobacter pylori Infection on Gastric Juice pH. Scandinavian Journal of Gastroenterology 33:4, pages 357-363.
Read now
Read now
Articles from other publishers (21)
Khean‐Lee Goh, Yeong Yeh Lee, Alex Hwong‐Ruey Leow, Raja Affendi Raja Ali, Shiaw Hooi Ho, Sanjiv Mahadeva, Rosaida Hj Mohd Said, Raman Muthukaruppan Chettiar & Hoi Poh Tee. (2023)
A Malaysian consensus report on the diagnosis and treatment of
Helicobacter pylori
infection
. JGH Open 7:4, pages 261-271.
Crossref
Crossref
A. H. Harb, J. M. Chalhoub, R. Abou Mrad & A. I. Sharara. (2015)
Systematic review and meta-analysis: full- vs. half-dose anti-microbials in clarithromycin-based regimens for
Helicobacter pylori
eradication
. Alimentary Pharmacology & Therapeutics 42:2, pages 131-141.
Crossref
Crossref
Ala I Sharara, Fayez S Sarkis, Mustapha M El-Halabi, Ahmad Malli, Nabil M Mansour, Cecilio Azar, Mohamad A Eloubeidi, Fadi H Mourad, Kassem Barada & Ismail Sukkarieh. (2014)
Challenging the dogma: a randomized trial of standard vs. half‐dose concomitant nonbismuth quadruple therapy for
Helicobacter pylori
infection
. United European Gastroenterology Journal 2:3, pages 179-188.
Crossref
Crossref
Nabil M. Mansour, Jana G. Hashash, Mustapha El-Halabi, Ola Ghaith, Karim Maasri, Ismail Sukkarieh, Ahmad Malli & Ala I. Sharara. (2011) A randomized trial of standard-dose versus half-dose rabeprazole, clarithromycin, and amoxicillin in the treatment of Helicobacter pylori infection. European Journal of Gastroenterology & Hepatology 23:10, pages 865-870.
Crossref
Crossref
Hidekazu Suzuki, Toshifumi Hibi & Barry James Marshall. (2007) Helicobacter pylori: present status and future prospects in Japan. Journal of Gastroenterology 42:1, pages 1-15.
Crossref
Crossref
T. Schaeverbeke, N. Broutet, F. Zerbib, B. Combe, P. Bertin, H. Lamouliatte, F. Perie, M. Joubert-Collin & F. Megraud. (2005) Should We Eradicate Helicobacter pylori Before Prescribing an NSAID? Result of a Placebo-Controlled Study. The American Journal of Gastroenterology 100:12, pages 2637-2643.
Crossref
Crossref
Rupert Wing-Loong Leong & Francis Ka-leung Chan. 2004. Encyclopedia of Gastroenterology. Encyclopedia of Gastroenterology
645
652
.
Mitsuru Seo, Mitsuo Okada, Takuro Shirotani, Hirokatsu Nishimura, Kazuhiro Maeda, Kunihiko Aoyagi & Shotaro Sakisaka. (2002) Recurrence of Helicobacter pylori Infection and the Long-term Outcome of Peptic Ulcer After Successful Eradication in Japan. Journal of Clinical Gastroenterology 34:2, pages 129-134.
Crossref
Crossref
Ala I Sharara, Marwan Chedid, George F Araj, Kassem A Barada & Fadi H Mourad. (2002) Prevalence of Helicobacter pylori resistance to metronidazole, clarithromycin, amoxycillin and tetracycline in Lebanon. International Journal of Antimicrobial Agents 19:2, pages 155-158.
Crossref
Crossref
D. Vaira, L. Gatta, C. Ricci, L. D'Anna & M. Miglioli. (2001) Helicobacter pylori: diseases, tests and treatment. Digestive and Liver Disease 33:9, pages 788-794.
Crossref
Crossref
Pius Hildebrand, Pradip Bardhan, Livio Rossi, Shahana Parvin, Anisur Rahman, Mohamed S. Arefin, Mahmud Hasan, Mian M. Ahmad, Katharina Glatz–Krieger, Luigi Terracciano, Peter Bauerfeind, Christoph Beglinger, Niklaus Gyr & Abul K. Azad Khan. (2001) Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults. Gastroenterology 121:4, pages 792-798.
Crossref
Crossref
R.H. Hunt, K. Sumanac & J.-Q. Huang. (2001)
Review article: should we kill or should we save
Helicobacter pylori
?
. Alimentary Pharmacology & Therapeutics 15, pages 51-59.
Crossref
Crossref
Yoshihiro KETO, Misako EBATA & Susumu OKABE. (2001) Pharmacological study on the pathological changes of the gastric mucosa in Helicobacter pylori-infected Mongolian gerbils.. Folia Pharmacologica Japonica 118:4, pages 259-268.
Crossref
Crossref
Robert R. Cima & David I. Soybel. 2001. Principles and Practice of Geriatric Surgery. Principles and Practice of Geriatric Surgery
555
568
.
Peter Malfertheiner, Andreas Leodolter & Ulrich Peitz. (2000) Cure of Helicobacter pylori -associated ulcer disease through eradication. Best Practice & Research Clinical Gastroenterology 14:1, pages 119-132.
Crossref
Crossref
Gina Martino, Marco Paoletti, Adriana Marcheggiano, Giancarlo D'ambra, Gianfranco Delle Fave & Bruno Annibale. (2001)
Duodenal Ulcer Relapse Is Not Always Associated with Recurrence of
H. pylori
Infection: A Prospective Three‐Year Follow‐Up Study
. Helicobacter 4:4, pages 213-217.
Crossref
Crossref
Matthias Trautmann, Christine Riediger, Angelika Möricke, Konstanze Vogt, Ulrich Bohr & Bernhard Glasbrenner. (2002)
Combined Activity of Azithromycin and Lansoprazole Against
Helicobacter pylori
. Helicobacter 4:2, pages 113-120.
Crossref
Crossref
Min WenYali Zhang, Nobutaka YamadaTakeshi MatsuhisaNorio MatsukuraYuichi Sugisaki. (2002)
An evaluative system for the response of antibacterial therapy: Based on the morphological change of
Helicobacter pylori
and mucosal inflammation
. Pathology International 49:4, pages 332-337.
Crossref
Crossref
A. T. Prach, M. Malek, M. Tavakoli, D. Hopwood, B. W. Senior & F. E. Murray. (1998)
H
2
-antagonist maintenance therapy versus
Helicobacter pylori
eradication in patients with chronic duodenal ulcer disease: a prospective study
. Alimentary Pharmacology & Therapeutics 12:9, pages 873-880.
Crossref
Crossref
Hazel M. Mitchell, Pinjin Hu, Yi Chi, Min Hu Chen, Yu Yuan Li & Stuart L. Hazell. (1998) A low rate of reinfection following effective therapy against Helicobacter pylori in a developing nation (China). Gastroenterology 114:2, pages 256-261.
Crossref
Crossref
Masukazu Inoie, Shigeki Marubuchi & Hirotoshi Arai. (1998) Histamine H2-Receptor Antagonism of T-593, an Anti-ulcer Agent: Studies on Aminopyrine Accumulation in Isolated Canine Gastric Mucosal Cells. Japanese Journal of Pharmacology 78:3, pages 313-322.
Crossref
Crossref